Announce Date | 05/07/2025 |
EPS Normalized Actual | $0.29 (Beat by $0.03) |
EPS GAAP Actual | $0.29 (Beat by $0.03) |
Revenue Actual | $2.977B |
Revenue Surprise | Beat by $2977M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.78238 |
EPS GAAP Estimate | $0.78238 |
Revenue Estimate | $2.8338407B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 4.11 | 12.6 | 3.92194 | 4.24451 | 0 |
Dec 2025 | 3.24646 | 15.95 | 2.86035 | 3.85092 | 6 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.81 | -0.81 | 2.977B | 16.02% | 2977M |
FQ4 2024 (Dec 2024) | 0.0008 | 0.0008 | 0.00325B | 20.31% | 3.25M |
FQ3 2024 (Sep 2024) | -0.0246 | -0.0246 | -5.29354B | 100.05% | -5293.54M |
FQ2 2024 (Jun 2024) | 0.0003 | 0.0003 | 0.002846B | 15.88% | 2.85M |
FQ1 2024 (Mar 2024) | -0.3 | -0.3 | 2.5B | 7.08% | 2500M |
FQ4 2023 (Dec 2023) | 0.0006 | 0.0006 | 0.00259B | -95150.97% | 2.59M |
FQ3 2023 (Sep 2023) | 0.0006 | 0.0006 | 0.002471B | 100% | 2.47M |
FQ2 2023 (Jun 2023) | 0.0005 | 0.0005 | 0.002394B | 100% | 2.39M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.78238
Consensus Revenue Estimates
2.8338407B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.1715 | -- | 1.08189 | 1.23159 | 2 |
FQ3 2027 (Sep 2027) | 0.9337 | -- | 0.86228 | 0.98159 | 2 |
FQ2 2027 (Jun 2027) | 1.0018 | -- | 0.92517 | 1.05319 | 2 |
FQ1 2027 (Mar 2027) | 0.7969 | -- | 0.73594 | 0.83778 | 2 |
FQ4 2026 (Oct 2026) | 0.99137 | -- | 0.93577 | 1.01779 | 3 |
FQ3 2026 (Jul 2026) | 0.95547 | -- | 0.90189 | 0.98093 | 5 |
FQ2 2026 (Jun 2026) | 0.95547 | -- | 0.90475 | 0.99573 | 5 |
FQ1 2026 (Mar 2026) | 0.71517 | 213.26 | 0.6772 | 0.74531 | 3 |
FQ4 2025 (Oct 2025) | 0.8901 | 99.91 | 0.84018 | 0.91382 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 4.69B | -- | 4.41B | 4.88B | 4 |
FQ3 2027 (Sep 2027) | 4.55B | -- | 4.28B | 4.73B | 4 |
FQ2 2027 (Jun 2027) | 4.41B | -- | 4.15B | 4.59B | 4 |
FQ1 2027 (Mar 2027) | 4.28B | -- | 4.03B | 4.45B | 4 |
FQ4 2026 (Oct 2026) | 3.39B | -- | 3.24B | 3.46B | 4 |
FQ3 2026 (Jul 2026) | 3.29B | -- | 3.15B | 3.36B | 6 |
FQ2 2026 (Jun 2026) | 9.07B | -- | 8.69B | 9.36B | 6 |
FQ1 2026 (Mar 2026) | 8.42B | 64.63 | 8.07B | 8.69B | 4 |
FQ4 2025 (Oct 2025) | 2.96B | 99.89 | 2.84B | 3.03B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.81 | -0.81 | 100% | |
FQ4 2024 (Dec 2024) | 0.0008 | 0.0008 | 100% | |
FQ3 2024 (Sep 2024) | -0.0246 | -0.0246 | 100% | |
FQ2 2024 (Jun 2024) | 0.0003 | 0.0003 | 100% | |
FQ1 2024 (Mar 2024) | -0.3 | -0.3 | 100% | |
FQ4 2023 (Dec 2023) | 0.0006 | 0.0006 | 100% | |
FQ3 2023 (Sep 2023) | 0.0006 | 0.0006 | 100% | |
FQ2 2023 (Jun 2023) | 0.0005 | 0.0005 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $2.98B | $2977M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0B | $3.25M | 100% |
FQ3 2024 (Sep 2024) | $0B | $-5.29B | $-5293.54M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0B | $2.85M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.5B | $2500M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0B | $2.59M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0B | $2.47M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0B | $2.39M | 100% |